Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Tom Gallen

Managing Editor – Europe

Having joined OTC bulletin as a business reporter in 2013, Tom is currently the managing editor and has an intimate knowledge of the global consumer healthcare market, particularly commercial and regulatory issues. He specializes in analyzing the strategies of the world's leading consumer healthcare companies, their business performance, plans and product portfolios.
Set Alert for Articles By Tom Gallen

Latest From Tom Gallen

Takeda Offloads Emerging Market OTCs to Acino

Takeda is shedding some unwanted OTC assets in a number of emerging markets as part of its efforts to pay down debt and focus its portfolio following its acquisition of Shire. 
Deals Emerging Markets

Brazil Prepares To Clear Backlog Of 25 Switch Applications

Brazil's drug regulator Anvisa is seeking comments on its backlog of 25 Rx-to-OTC switch applications as it looks to make more prescription products available OTC.
Prescription To Otc Switch South America

Lack Of Harmonization Holding Back EU Supplements Market

EU-wide harmonization is needed for regulations governing maximum safety levels for vitamins and minerals in food supplements to facilitate the creation of a true single market, argues French industry body Synadiet.
Europe Dietary Supplements

French OTC Industry Warns Over-Regulation Is Threatening Its Future

Plans to move ibuprofen, aspirin and paracetamol OTCs behind the counter in French pharmacies will harm the country's self-medication industry, which is already lagging behind its European neighbors, warns local association Afipa.
France OTC Drugs

Germany And Sweden Leading The EU In CBD Enforcement Action

Sweden and Germany are cracking down on unauthorized CBD food products and warning their neighbors of the health risks posed to consumers, an analysis by HBW Insight reveals. A large proportion of these CBD products are being sold as food supplements and many originate from the Netherlands. 
Regulation Dietary Supplements

EMA Tells Firms To Evaluate OTCs For Carcinogenic Nitrosamines

Firms operating in the EU given six months to evaluate all OTC drugs containing chemically synthesized APIs for presence of nitrosamines, a probable human carcinogen. The order from EMA comes with a review of ranitidine underway after nitrosamine NDMA was detected in a number of OTC and Rx drugs.
Health Drug Review
See All